Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 10Congress 0Executive branch 0Insiders 10
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

SYRE · sells only · $1M+ · 10 trades

Trades
10
Buys 0 · Sells 10
People
8
Stocks
1
Disclosed value
$1.6B
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$1.5Mdisclosed Oct 2 · filed 1 day after the trade
  2. ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$1.6Mdisclosed Oct 2 · filed 2 days after the trade
  3. ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$1.6Mdisclosed Sep 3 · filed 1 day after the trade
  4. ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$1.4Mdisclosed Sep 3 · filed 2 days after the trade
  5. ▼ SELLJeffrey W. Albers DirectorSYRE Spyre Therapeutics, Inc.$1Mdisclosed Aug 10 · filed 3 days after the trade
  6. ▼ SELLMichael Thomas Henderson DirectorSYRE Spyre Therapeutics, Inc.$2Mdisclosed Jun 23 · filed 1 day after the trade
  7. ▼ SELLPeter Evan Harwin DirectorSYRE Spyre Therapeutics, Inc.$400Mdisclosed Jun 23 · filed the same day
  8. ▼ SELLTomas Kiselak DirectorSYRE Spyre Therapeutics, Inc.$400Mdisclosed Jun 23 · filed the same day
  9. ▼ SELLFairmount Funds Management LLC DirectorSYRE Spyre Therapeutics, Inc.$400Mdisclosed Jun 23 · filed the same day
  10. ▼ SELLFairmount Healthcare Fund II L.P. DirectorSYRE Spyre Therapeutics, Inc.$400Mdisclosed Jun 23 · filed the same day